|
Originally published In Press as doi:10.1074/jbc.M102751200 on June 26, 2001
J. Biol. Chem., Vol. 276, Issue 34, 31760-31771, August 24, 2001
Functional Characterization of Mutants in the Predicted Pore
Region of the Rabbit Cardiac Muscle Ca2+ Release Channel
(Ryanodine Receptor Isoform 2)*
Guo Guang
Du ,
Xinghua
Guo,
Vijay K.
Khanna, and
David H.
MacLennan§
From the Banting and Best Department of Medical Research,
University of Toronto, Toronto, Ontario M5G 1L6, Canada
Received for publication, March 28, 2001, and in revised form, June 11, 2001
 |
ABSTRACT |
A highly conserved amino acid sequence,
GVRAGGGIGD4831, which may form part of the
Ca2+ release channel pore in RyR2, was subjected to Ala
scanning or Ala to Val mutagenesis; function was then measured by
expression in HEK-293 cells, followed by Ca2+ photometry,
high affinity [3H]ryanodine binding, and single-channel
recording. All mutants except I4829A and I4829T (corresponding to the
I4897T central core disease mutant in RyR1) displayed caffeine-induced
Ca2+ release in HEK-293 cells; only mutants G4826A, I4829V,
and G4830A retained high affinity [3H]ryanodine binding;
and single-channel function was found for all mutants tested, except
for G4822A and A4825V. EC50 values for caffeine-induced
Ca2+ release were increased for G4822A, R4824A, G4826A,
G4828A, and D4831A; decreased for V4823A; and unchanged for A4825V,
G4827A, I4829V, and G4830A. Ryanodine (10 µM), which did
not stimulate Ca2+ release in wild type (wt), did so in Ala
mutants in amino acids 4823-4827. It inhibited the caffeine response
in wt and most mutants, but enhanced the amplitude of caffeine-induced
Ca2+ release in mutant G4828A. It also restored
caffeine-induced Ca2+ release in mutants I4829A and I4829T.
In single-channel recordings, mutants I4829V and G4830A retained normal
conductance, whereas all others had decreased unitary channel
conductances ranging from 27 to 540 picosiemens. Single-channel
modu-lation was retained in G4826A, I4829V, and G4830A, but was
lost in other mutants. In contrast to wt and G4826A, I4829V, and
G4830A, in which divalent metals were preferentially conducted, mutants
with loss of modulation had no selectivity of divalent cations over a
monovalent cation. Analysis of Gly4822 to
Asp4831 mutants in RyR2 supports the view that this highly
conserved sequence constitutes part of the ion-conducting pore of the
Ca2+ release channel and plays a key role in ryanodine and
caffeine binding and activation.
 |
INTRODUCTION |
Ryanodine receptors
(RyRs)1 and inositol
1,4,5-trisphosphate (IP3) receptors form a family of
Ca2+ release channels that play an essential role in the
regulation of intracellular Ca2+ levels, thus impacting on
a variety of physiological functions (1-3). The RyR channels are
homotetramers of ~565-kDa subunits located in the sarco(endo)plasmic
reticulum of muscle and nonmuscle cells. Analysis of the deduced amino
acid sequence, which consists of about 5000 amino acids in skeletal and
cardiac muscle RyRs, has led to the prediction that transmembrane
sequences near the COOH terminus form the Ca2+ conducting
pore, while the remainder of the molecule forms a series of cytoplasmic
domains (4-6).
Several important regions have been mapped with low resolution through
structure/function analysis of the linear amino acid sequence of RyRs.
Malignant hyperthermia (MH) and central core disease (CCD) mutations,
found in the sequences lying between amino acids 35 and 614 (MH/CCD
domain I), 2162 and 2458 (MH/CCD domain II), and 4793 and 4897 (MH/CCD
domain III), alter sensitivity of the channel to caffeine and halothane
(7-10). Several mutations, recently found in two regions equivalent to
MH/CCD domains I and II in RyR1, and also a COOH-terminal region (amino
acids 4104-4497) in human cardiac RyR2, are associated with
catecholaminergic polymorphic ventricular tachycardia and
arrhythmogenic right ventricular cardiomyopathy type 2 (11, 12).
Locations of some ligand binding sites in the molecule have also been
mapped. Ca2+ activation sites (13, 14), Ca2+
inactivation sites (15-17), and high affinity
[3H]ryanodine binding sites (18, 19) are localized to the
COOH-terminal quarter of RyR1. Mutation of Glu3885 in
predicted transmembrane sequence 2 (TM2) of RyR3 (equivalent to
Glu4032 in RyR1) caused a huge decrease in Ca2+
sensitivity (14). Other mutations of acidic amino acids in TM2, TM7,
and TM10 have also been shown to block caffeine and 4-chloro-m-cresol activation and high affinity ryanodine
binding, but single-channel function was not analyzed (20). The
COOH-terminal one-fifth of the molecule retains sufficient structure to
form a functional Ca2+ release channel, but lack of
regulation of this channel suggests that upstream sequences contain
regulatory elements (13). Although several potential calmodulin binding
sites have been identified (21, 22), Cys3635 in RyR1
appears to be critical for calmodulin binding and redox modulation
(23).
One CCD mutation, I4897T, associated with severe clinical symptoms,
abolished caffeine-induced Ca2+ release and high affinity
[3H]ryanodine binding when RyR1 bearing this mutation was
expressed in HEK-293 cells (10). It was proposed that the I4897T
mutation was leaky, depleting Ca2+ stores. However, a later
study of the I4897T mutant, expressed in dyspedic myotubes,
demonstrated a functional uncoupling of sarcolemmal excitation from
Ca2+ release from the sarcoplasmic reticulum (24). In that
study, Ca2+ stores were reported to be similar when wt RyR1
or I4897T mutant RyR1 were expressed in the dyspedic myotubes. The
I4897T mutation is located in a highly conserved sequence in predicted
TM9, between two of the most likely transmembrane helices (TM8 and
TM10) (5). This sequence is GVRAGGGIGD in the RyR family and
GLR(S/N)GGG(I/V)GD in the IP3 receptor family. The GIG
motif is similar to the K+ channel pore region motif, GYG
(25), leading to the proposal that this sequence might form part of the
pore of the RyR Ca2+ release channel (26, 27).
In support of this proposal, the mutation G4824A in mouse RyR2 reduced
single-channel conductance from 798 pS for the wild type channel to 22 pS (27). Agents such as Ca2+, Mg2+, ATP,
caffeine, ruthenium red, and ryanodine modulated the mutant channel.
Co-expression of wild type and G4824A mutant proteins yielded single
channels with intermediate unitary conductances. Several mutations in
this region also abolished high affinity [3H]ryanodine
binding. Selected mutations in this region or in adjacent regions in
RyR1 altered channel conductance in a separate study, but some of these
mutations were otherwise unregulated in single-channel recordings
(28).
In this study, we carried out systematic Ala or Ala to Val scanning
mutagenesis of all amino acids in this highly conserved and
disease-inducing region. Mutant channel function was analyzed by
measurement of ligand-induced Ca2+ release in transfected
HEK-293 cells using Ca2+ photometry,
[3H]ryanodine binding in whole cell extracts, and
single-channel recordings with partially purified proteins. We found
alterations in regulation and in caffeine and ryanodine modulation of
the channels, alterations in conductivity and ion selectivity, and abnormal interactions between ryanodine and caffeine that imply a close
relationship between the effects of these two modulators.
 |
EXPERIMENTAL PROCEDURES |
Materials--
Restriction endonucleases and other DNA modifying
enzymes were from Stratagene, Roche Molecular Biochemicals, New England Biolabs, Promega, and Amersham Pharmacia Biotech; Fura-2 acetoxymethyl ester (AM) was from Molecular Probes; caffeine and protease inhibitors were from Sigma; [3H]ryanodine was from PerkinElmer Life
Sciences; unlabeled ryanodine was from Calbiochem; CHAPS was
from Bio-Rad; soybean phosphatidylcholine (PC) was from Northern
Lipids. The expression vector pcDNA 3.1( ) was from Invitrogen.
Monoclonal antibody C3-33 was from Affinity Bioagents. All other
reagents were of reagent grade or highest grade available.
Oligonucleotide-directed Mutagenesis--
Site-directed
mutagenesis of the pore region residues was carried out in a small
fragment (SacI-BglII, 13602-14526) of RyR2 cDNA by Pfu polymerase-based polymerase chain reaction
using the Quickchange kit (Stratagene). The complete sequence of the
mutated fragment was confirmed by DNA sequencing. The fragment with the desired mutation was subcloned back into its original position in RyR2
by three steps of subcloning: to a vector containing
SacI-BspEI (13602-14880), then to a vector
containing fragment SacII-XhoI (11206-15360),
and, finally, to the full-length RyR2 in the pcDNA expression vector.
Cell Culture and DNA Transfection--
The culture of HEK-293
cells and cDNA transfection by the calcium phosphate precipitation
method were carried out as described previously (29).
Fluorescence Measurements--
A microfluorimetry system (Photon
Technologies Inc.) was used to monitor the Fura-2 AM fluorescence
changes in transiently transfected or non-transfected HEK-293 cells, as
described previously (30).
Extraction of Recombinant RyR2 and Mutant
Proteins--
Transfected HEK-293 cells grown in 100-mm Petri dishes
were solubilized with 1% CHAPS, 5 mg/ml phosphatidylcholine, and a protease inhibitor mix (0.1 mM AEBSF, 1 mM
benzamidine, 1 µg/ml each of leupeptin, pepstatin, aprotinin, and
E64) at 4 °C for 1 h, as described previously (30). After
precipitation at 8000 × g (Sorvall ss34 rotor) for 20 min, the supernatant was used for a [3H]ryanodine binding
assay or was further centrifuged at 45,000 × g for
1 h in a Beckman rotor Ti70.1. The resulting pellet was dissolved
in 250 mM sucrose, 150 mM KCl, 25 mM HEPES, pH 7.1, for measurement of
[3H]ryanodine binding, as described below, or used for
purification of RyR2 and mutant proteins by sucrose gradient
centrifugation, as described below.
[3H]Ryanodine Binding--
Channel opening was
analyzed using the [3H]ryanodine binding assay described
previously (30). In brief, about 50 µg of protein were added to a
binding buffer composed of 0.5 M KCl, 1 mM ATP, 100 µM free Ca2+, 0.2 mM EGTA, 50 mM HEPES, pH 7.1, and various concentrations of
[3H]ryanodine in a total volume of 0.25 ml. Nonspecific
binding was determined using a 1000-fold excess of unlabeled ryanodine. After 2 h at 37 °C, the samples were diluted with 1 ml of
ice-cold washing buffer composed of 25 mM HEPES, pH 7.1, and 0.25 M KCl and placed on Whatman GF/B membrane filters
pre-soaked with 1% polyethyleneimine in washing buffer. Filters were
washed three times with 6 ml of washing buffer.
[3H]Ryanodine bound to the filter was quantified by
liquid scintillation counting. All binding assays were carried out in duplicate.
Purification of Expressed RyR2 and Mutant Proteins for
Single-channel Recording--
The pellet obtained after centrifugation
at 45,000 × g (see above) was solubilized for 1 h
in a buffer composed of 1 M NaCl, 1% CHAPS, 5 mg/ml PC, a
mix of protease inhibitors (0.1 mM AEBSF, 1 mM
benzamidine, 1 µg/ml each of leupeptin, pepstatin, aprotinin, and
E64) and 50 mM Hepes, pH 8.0. After centrifugation at
30,000 × g for 30 min, the supernatant was placed on
the top of a 7-25% (w/v) linear sucrose gradient solution containing
50 mM Tris-HEPES, pH 7.4, 0.3 M NaCl, 0.1 mM CaCl2, 0.3% CHAPS, 0.15% PC, and the protease inhibitor mix, and was centrifuged at 28,000 rpm in a Beckman
SW-40 rotor for 16-18 h at 4 °C. Fractions of about 0.75 ml each
were collected from bottom to top and subjected to direct enzyme-linked
immunosorbent assay using monoclonal antibody C3-33 to determine the
portion that contained RyR protein. The fractions with peak
immmunoreactivity were collected and stored at 70 °C.
Single-channel Recording--
Single-channel activities were
recorded after incorporation of sucrose density gradient-purified wild
type and mutant RyR2 proteins into a planar lipid bilayer. The bilayer
was formed by painting a lipid mixture (5:3
phosphatidylethanolamine:phosphatidylcholine, 35 mg/ml) across a
200-µm hole in a Delrin partition separating two chambers (Warner
Instrument Corp.). The trans chamber was connected to the
head stage input of an amplifier (model EPC-7, List Electronics). The
cis chamber was virtually grounded. Unless stated otherwise,
single-channel recordings were obtained with a symmetrical solution
containing 250 mM KCl and 25 mM Hepes, pH 7.4. After formation of the bilayer, a 3-µl aliquot of the sample was
added to the cis chamber with continuous stirring of both
chambers. Voltage commands to the amplifier were given through a
Digidata 1200 (Axon Instruments Inc.). Recordings were filtered at 1 kHz before being acquired at 5 kHz by the Digidata 1200.
Data Analysis--
Ca2+ photometric data were
analyzed with Felix software (Photon Technologies Inc.). Single-channel
recording data were analyzed using pClamp 7.0 software (Axon
Instruments inc.). Scatchard analysis was used to determine the
dissociation constant (Kd) and maximal binding
capacity (Bmax) from equilibrium binding data. EC50 values were obtained by fitting the curves with an
equation for logistic dose response using Microcal Origin software
(Microcal Software Ltd., Northampton, MA). Data are expressed as
mean ± S.E. A paired or unpaired Student t test was
used for evaluation of the mean values. A value of p 0.05 was considered to be statistically significant.
 |
RESULTS |
Site-directed Mutagenesis and Expression of Mutant RyR2--
In
this study, most residues in the highly conserved sequence
GVRAGGGIGD4831 in RyR2 were mutated to the small, non-polar
residue Ala, Ala4825 was mutated to Val, and
Ile4829, the residue equivalent to Ile4897 in
RyR1, was mutated to Ala and Val and to Thr, a mutation that causes a
clinically severe form of central core disease in humans (10). Wild
type and mutant RyR2 cDNAs were transfected transiently into
HEK-293 cells. All proteins were expressed at readily detectable levels, as judged by functional assays such as caffeine-induced Ca2+ release and [3H]ryanodine binding and by
Coomassie Blue staining and Western blotting of whole cell lysates with
monoclonal antibody C3-33 (data not shown).
Fluorescence Measurement of Caffeine-induced Ca2+
Release--
Fura-2 fluorescence was measured at excitation
wavelengths of 340 and 380 nm. Changes in the 340/380 ratio provided a
measure of ligand-induced Ca2+ release in HEK-293 cells
transfected with wt or mutant RyR2 (30). Since the measurement was
carried out by photometry, resting intracellular Ca2+
levels could not be measured accurately.
No significant Ca2+ release was observed with caffeine up
to 30 mM in pcDNA-transfected cells (30), but
caffeine-induced Ca2+ release was readily observed in cells
transfected transiently with wt RyR2. Figs.
1 (A-C) show representative
traces of fluorescence changes for wt, V4823A, and G4828A that
represent changes in intracellular Ca2+ levels in response
to incremental application of 0.03-30 mM caffeine. Ca2+ release occurred with 0.03-0.1 mM
caffeine for wt and mutant V4823A, but was seen only with
concentrations of caffeine above 3 mM for G4828A. Peak
fluorescence amplitudes were measured following the incremental
application of 0.03-30 mM caffeine and normalized to the
peak amplitude for maximal Ca2+ release induced by 30 mM caffeine. Since caffeine at concentrations as high as 50 or 100 mM quenched fluorescence of the dye, a proper value
for maximal Ca2+ release could not be obtained at these
concentrations of caffeine. EC50 values were calculated by
fitting the caffeine dose-response curves with an equation for logistic
dose response. Dose-response curves for wt and mutant RyR2 proteins are
shown in Fig. 1D, and EC50 values are summarized
in the inset to Fig. 1D.

View larger version (33K):
[in this window]
[in a new window]
|
Fig. 1.
Fluorescence measurements of Ca2+
release by incremental concentrations of caffeine in HEK-293 cells
transfected with wild type and mutant RyR2
cDNAs. Representative fluorescence tracings are shown
for HEK-293 cells expressing RyR2 (A), V4823A
(B), or G4828A (C) following incremental
additions of caffeine. Caffeine dose-response curves are shown in
D. Cells cultured on a coverslip were loaded with 2 µM Fura-2 AM and mounted on the stage of an inverted
microscope, where selected fields containing about 30 cells were
challenged with caffeine (30). Caffeine was washed out to restore
resting Ca2+ levels after measurement of each peak
amplitude (peak of change in the ratio of fluorescence at 340/380 nm)
indicated that peak changes in
[Ca2+]i had been obtained.
Individual peak amplitudes of 340/380 nm ratio (fluorescence ratio at
the highest response to caffeine minus the ratio at rest) were
collected and normalized to the maximal amplitude of the peak response
in fluorescence ratio (340/380 nm) caused by 30 mM
caffeine. The resulting data for all the mutants in this study were
averaged in D and expressed as mean ± S.E.
EC50 values and Hill coefficients, presented in the
inset to D, were obtained by fitting the
dose-response curves with an equation for logistic dose response. *,
p < 0.05 when compared with the EC50 value
for wild type RyR2.
|
|
No caffeine-induced Ca2+ release was observed for mutants
I4829A and I4829T, as reported previously (10). When I4829A and 4829T
were co-expressed with wild type RyR2 (in a ratio of 1:1 or 2:1), the
heterozygotes responded to caffeine with normal EC50 (data
not shown). Mutants G4822A, R4824A, G4826A, G4828A, and D4831A
displayed decreased caffeine sensitivity, while mutant V4823A displayed
increased caffeine sensitivity. Mutants A4825V, G4827A, I4829V, and
G4830A retained normal caffeine sensitivity. Hill coefficients for
mutants with normal or increased caffeine sensitivity were close to the
wt value of 1.1, while Hill coefficients for mutants with decreased
caffeine sensitivity were near 2, indicating co-operativity for
caffeine-induced Ca2+ release. Higher Hill coefficient in
these mutants could also result from a miscalculation of maximal
release, since we were unable to establish saturation for
caffeine-induced Ca2+ release in these mutants for the
reason outlined above.
Fluorescence Measurement of Ryanodine-induced Ca2+
Release--
As shown previously (30), 10 or even 100 µM
ryanodine did not elicit Ca2+ release in wt
RyR2-transfected cells (Figs.
2A and
3A) or pcDNA-transfected cells (data not shown) over a period of 3-4 min. Under the same conditions, no Ca2+ release was induced by 10 µM ryanodine in cells transfected with mutants G4822A,
G4828A, I4829A, I4829T, I4829V, G4830A, and D4831A (Figs. 2
(B, H, and I-K) and 3 (B
and C). By contrast, ryanodine induced Ca2+
release in cells transfected with mutants V4823A, R4824A, A4825V, G4826A, and G4827A (Fig. 2, C-G). The most significant
Ca2+ release occurred in mutants R4824A and G4827A (Fig. 2,
D and G). When mutants I4829A and I4829T were
co-expressed with wt RyR2 in a ratio of 1:1 or 2:1, Ca2+
release was induced by ryanodine in the heterozygote-transfected cells
(data not shown).

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 2.
Ryanodine stimulatory and inhibitory effects
on wild type and mutant proteins expressed in HEK-293 cells.
Ca2+ fluorescence measurement was used to monitor the
changes in cytoplasmic Ca2+ concentration in transfected
HEK-293 cells as described in the legend to Fig. 1. Ryanodine (10 µM) was added before or after a 10 mM
caffeine challenge. Note the changes in CA2+ transients in
mutants of Val4823 through Gly4827 after the
addition of ryanodine. The first addition of 10 mM caffeine
after the addition of ryanodine induced Ca2+ release in wt
and all mutants. Further additions of 10 mM caffeine did
not elicit Ca2+ release in RyR2 and all mutants except
G4828A. In cells transfected with this mutant, subsequent
caffeine-induced Ca2+ release was enhanced by the prior
addition of ryanodine.
|
|

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 3.
Ryanodine-enhanced caffeine-induced
Ca2+ release in cells transfected with mutants
I4829A and I4829T. Representative traces of Ca2+
fluorescence measurements used to monitor the changes in cytoplasmic
Ca2+ concentration in response to 10 mM
caffeine and 10 µM ryanodine in HEK-293 cells expressing
RyR2 (A), I4829A (B), or I4829T (C).
Two responses of similar amplitude were obtained following the addition
of 10 mM caffeine to HEK-293 cells expressing RyR2
(A) were obtained before the addition of 10 µM
ryanodine. The subsequent addition of 10 mM caffeine caused
one Ca2+ release similar to that before the addition of
ryanodine, but subsequent responses to caffeine were blocked. Mutants
I4829A (B) and I4829T (C) were not responsive to
caffeine at concentrations up to 30 mM as shown in Fig.
1D. However, 10 mM caffeine induced
Ca2+ release following the addition of 10 µM
ryanodine. The amplitude of subsequent caffeine-induced
Ca2+ release transients was gradually diminished.
|
|
Fluorescence Measurement of Interactions between Ryanodine and
Caffeine to Induce Ca2+ Release--
The effect of
ryanodine on caffeine-induced Ca2+ release was then
examined in wt and mutant RyR2. Caffeine-induced Ca2+
release could be obtained repeatedly in wt-transfected cells, provided
that caffeine was washed out between applications. The first
application of 10 mM caffeine after the addition of
ryanodine induced a Ca2+ release phase with undiminished
amplitude (Fig. 3A). The amplitude of Ca2+
release in response to further caffeine challenges was greatly diminished and eventually was lost (Figs. 2A and
3A). Similar results were obtained for cells transfected
with mutants G4822A, V4823A, R4824A, A4825V, G4826A, G4827A, I4829V,
G4830A, and D4831A (Fig. 2, B, C,
E-G, and I-K). By contrast, caffeine-induced
Ca2+ release in cells transfected with mutant G4828A (Fig.
2H) was resistant to ryanodine inhibition. Moreover, the
amplitude of caffeine-induced Ca2+ release was increased by
51% (± 19%, n = 3) after treatment of 10 µM ryanodine in cells transfected with mutant G4828A
(Fig. 2H).
A ryanodine-induced increase in caffeine-induced Ca2+
release was most obvious in cells transfected with mutants I4829A and I4829T (Fig. 3, B and C). In the homozygous form,
cells transfected with mutant I4829A or I4829T did not respond to
caffeine concentrations as high as 30 mM nor to ryanodine
at 10 µM. However, when 10 µM ryanodine was
applied before caffeine, 10 mM caffeine elicited significant Ca2+ release. Caffeine-induced Ca2+
release could be inhibited by continued incubation with 10 µM ryanodine. These results are summarized in Table
I.
View this table:
[in this window]
[in a new window]
|
Table I
Summary of results for caffeine- and ryanodine-induced Ca2+
release in transfected HEK-293 cell and [3H]ryanodine binding
to recombinant expressed wt and mutant RyR2
|
|
High Affinity Equilibrium Binding of [3H]Ryanodine to
Mutant RyRs--
The equilibrium properties of
[3H]ryanodine binding to mutant RyRs were measured to
determine whether the high affinity ryanodine binding site was
preserved. Surprisingly, high affinity [3H]ryanodine
binding could not be detected in most of the mutants. Scatchard
analysis showed a single binding site only in mutants G4826A, I4829V,
and G4830A (Fig. 4A).
Kd values for these mutants were similar to wild
type RyR2 (Ref. 30; Fig. 4A, inset). Bmax values for mutants G4826A, I4829V, and
G4830A were 1.6, 1.0, and 1.5 pmol/mg of lysate protein. These data
indicate that the high affinity ryanodine binding site is normal only
in mutants G4826A, I4829V, and G4830A.

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 4.
Scatchard analysis (A) and
Ca2+ dependence (B) of high affinity
[3H]ryanodine binding to wild type RyR2 and mutant
proteins from transfected HEK-293 cells. A, HEK-293
cells transfected with RyR2 or mutant cDNAs were solubilized in a
buffer containing NaCl 150 mM, Hepes 25 mM, pH
7.4, 1% CHAPS, and 5 mg/ml PC, and treated as described under
"Experimental Procedures." Aliquots of 25 µl of each sample were
incubated with various concentrations of [3H]ryanodine
(0.156-20 nM) in binding buffer containing 1 mM ATP and 100 µM free Ca2+ in a
total volume of 0.25 ml at 37 °C for 2 h. Specific
[3H]ryanodine binding was determined by filtration, as
described under "Experimental Procedures."
[3H]Ryanodine bound/Free (picomoles/mg of
protein/nM) was plotted as a function of
[3H]ryanodine bound (picomoles/mg of protein). Results
for Bmax and Kd were obtained
by linear fitting and are presented in the inset to
A. B, Ca2+ dependence of
[3H]ryanodine binding for wild type RyR2 and mutants
G4826A, I4829V, and G4830A. Protein samples were from a 45,000 × g spin of solubilized supernatant, as described under
"Experimental Procedures." Aliquots of 10-µl samples were
incubated for 2 h at 37 °C with 5 nM
[3H]ryanodine in a buffer containing different
Ca2+ concentrations in a total volume of 0.25 ml.
|
|
The Ca2+ dependence of [3H]ryanodine binding
was also determined for each mutant (Fig. 4B).
EC50 values (pCa) for Ca2+ activation for
mutants G4826A, I4829V, and G4830A were 6.06, 6.01, and 6.01, respectively, compared with 5.98 for wt. No significant [3H]ryanodine binding was observed for the other mutants
in the presence of Ca2+ at concentrations up to 1.5 pCa
units, even when supplemented by 10 mM caffeine and 3 mM ATP, which enhance channel opening (data not shown).
Single-channel Unitary Conductance and Gating--
Single-channel
conductance, gating, modulation, and permeability were determined for
wt RyR2 and most of the mutants using the planar lipid bilayer method
with K+ as the current carrier. Typical single-channel
current traces are shown in Fig. 5 for
wt RyR and mutants G4823A, R4824A, G4826A, G4827A, G4828A, I4829A,
I4829T, I4829V, G4830A, and D4831A. Channel open probability was 0.09, 0.01, 0.08, and 0.02 for wt RyR2, G4826A, I4829V, and G4830A in the
presence of trace amounts (about 300 nM) of
Ca2+, and each of these channels displayed gating behavior
that was similar to wt in terms of mean open and mean closed time (data not shown). Channel open probability, however, was much higher for all
other mutant channels in the presence of trace (~300 nM) amounts of Ca2+ (Fig. 5). These channels were not closed,
even in the presence of 1-3 mM EGTA, indicating that they
required almost no Ca2+ for opening under the conditions of
the in vitro assay. Among these mutants, single-channel
activity for G4828A was observed only after overnight treatment with
50-200 µM ryanodine.

View larger version (74K):
[in this window]
[in a new window]
|
Fig. 5.
Representative single-channel recordings for
wild type or mutant RyR2 expressed in HEK-293 cells.
Single-channel currents, shown as downward inflections from the closed
level indicated by a short line to the
left of each trace, were recorded at 30 mV for all, except
120 mV for G4826A, in symmetrical 250 mM KCl solution
containing trace (~300 nM) Ca2+. Traces were
filtered at 1 kHz, with the exception of G4826A, which was filtered at
200 Hz.
|
|
Unitary single-channel conductances, calculated from the
current/voltage curves shown in Fig.
6A for wt and mutants, are
presented in Fig. 6B (see also Fig. 5). Mutants I4829V and
G4830A had single-channel conductances similar to that of wt RyR2. All
other mutants had significantly lower conductances than wt. Among them,
G4826A had a conductance of about 27 pS, a 26-fold reduction when
compared with the wt channel. This finding is consistent with
observations for the same mutant in mouse RyR2 and rabbit RyR1 (27,
28).

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 6.
Current-voltage curves (A)
and calculated maximal unitary conductances (B) for
wild type or mutant RyR2 expressed in HEK-293 cells.
Single-channel recordings were obtained in symmetrical 250 mM KCl solution containing trace Ca2+. The
number of experiments carried out is indicated in B. *,
p < 0.05 when compared with the conductance value for
wild type RyR2.
|
|
Single-channel Modulation--
Fig.
7 shows representative single-channel
recordings of wt RyR2 and mutants G4826A, G4828A, and I4829V following
the addition of a number of physiological and pharmacological agents
that modulate native RyR2 channels. The response of CHAPS-solubilized
and sucrose gradient-purified recombinant wt RyR2 to modulators such as
Ca2+, Mg2+, ATP, caffeine, ryanodine, and
ruthenium red was unchanged from the responses of the native channel
(Fig. 7A). In the presence of 100 µM
Ca2+ in the cis chamber, the Ca2+
release channel was activated with a Po of 0.56. The addition of 1.0 mM EGTA to the cis chamber,
lowering free Ca2+ to 0.08 µM, completely
inhibited channel activity. Elevation of free Ca2+ to 100 µM by the addition of 1 mM CaCl2
increased the Po to 0.33. The subsequent
addition of 3 mM MgCl2 inhibited channel
activity and reduced the Po to 0.001. The
addition of ATP to 3 mM, then caffeine to 3 mM,
increased the Po to 0.05 and 0.45, respectively. Ryanodine (10 µM) reduced channel conductance to 50% of
the unmodified state and shifted it to a long-lived open state.
Ruthenium red (10 µM) blocked the ryanodine-modified
channel.

View larger version (50K):
[in this window]
[in a new window]
|
Fig. 7.
Single-channel modulation of RyR2 and mutants
G4826A, G4828A, and I4829V. Single-channel currents were recorded
for RyR2 (A), G4826A (B), G4828A (C),
and I4829V (D) in symmetrical 250 mM KCl and are
shown as downward inflections from a closed state indicated by the
line cross each trace. The holding potential was
60 mV for RyR2, 80 mV for G4826A, and 30 mV for G4828A and
I4829V. Sequential additions of EGTA, CaCl2,
MgCl2, ATP, caffeine, ryanodine, and ruthenium red (in the
left panel) were made into the cis
chamber, except for G4828A, where additions were made into both the
cis and trans chambers. The order of addition of
MgCl2 and ATP was changed for mutant samples. The dose of
each agent and channel open probability (Po) are
shown on the top of each trace. Note that
Po for G4828A was not affected by these
agents.
|
|
Among the mutants tested, G4830A, with normal conductance and gating
behavior, responded to these modulators with a pattern similar to that
displayed by wt RyR2 (Table II). Mutant
G4826A, despite its greatly reduced conductance, and mutant I4829V also displayed wt modulation by Ca2+, Mg2+, ATP,
caffeine, ryanodine, and ruthenium red (Fig. 7, panels B and
D). However, mutant G4828A, which displayed caffeine-induced Ca2+ release in transfected HEK-293 cells, did not respond
to any of the ligands at concentrations shown routinely to modulate wt RyR2 channels (Fig. 7C). In addition, mutants V4823A,
R4824A, G4827A, I4829A, I4829T, and D4831A were not modulated by any of these ligands (Table II).
View this table:
[in this window]
[in a new window]
|
Table II
Modulation of wt and mutant RyR2 single channels by Ca2+,
Mg2+, ATP, caffeine, ryanodine, ruthenium red, and heparin
+, positive response; ND, not detected; NT, not tested.
|
|
The effect of higher concentrations of both ryanodine and ruthenium red
was tested on mutant channels that did not respond to ligands. Fig.
8 shows the effects of these two
modulators on the single-channel activity of mutant G4828A when applied
at higher concentrations. This experiment was carried out at very low
Ca2+ concentrations, with 1 mM EGTA in both the
cis and trans chambers; ryanodine and ruthenium
red were added subsequently to both chambers. Under these conditions,
the G4828A channel remained in the open state, even in the presence of
10 µM ryanodine or 10 µM ruthenium red
(data not shown). Higher concentrations of ryanodine (60 and 100 µM) gradually induced a long-lived close time but did not affect channel conductance. Ruthenium red at 100 and 400 µM blocked the channel. Thus, the purified G4828A,
I4829A, or I4829T channels were all affected in atypical fashion by
ruthenium red and ryanodine, the most prominent change being a
substantial decrease in affinity (Table II). None of the other
non-modulated mutants responded to ryanodine as high as 300 µM or to ruthenium red as high as 1.2 mM
(Table II).

View larger version (42K):
[in this window]
[in a new window]
|
Fig. 8.
Single-channel modulation of G4828A by high
concentrations of ryanodine and ruthenium red. Single-channel
currents were recorded at 30 mV in symmetrical 250 mM KCl
and are shown as downward inflections from a closed state indicated by
the line across each trace. Sequential
additions of ryanodine and ruthenium red were made into both the
cis and trans chamber. The dose of each agent is
shown on the top of each trace.
|
|
Heparin, an IP3 receptor antagonist, was tested on wt RyR2
and some mutants. Neither stimulatory nor inhibitory effects were found
for wt or mutants V4823A, R4824A, G4828A, I4829A, or I4829T (Table II)
after the addition of 100-1000 µg/ml heparin to both the
cis and trans chambers.
In an attempt to determine whether cellular accessory factors might
regulate the properties of the mutant channels, we extracted about 200 µl of HEK-293 cell fluid from five 100-mm plates of confluent cells
by homogenization and centrifugation at 10,000 × g for
30 min. Wild type RyR2, mutant V4823A, and mutants retaining modulatory
function did not respond when up to 3 µl of the fluid were added to
the cis and/or trans chambers (data not shown). However, the addition of 1-3 µl of cell fluid to the cis
chamber in the presence of 0.5 mM EGTA or 100 µM Ca2+ blocked channel opening for mutants
R4824A, G4827A, G4828A, I4829A, I4829T, and D4831A. Blockage was not
reversed by the addition of Ca2+, ATP, or caffeine.
Although the effective component in the cell fluid is not known and
modulation is clearly not typical, the results provide a hint for why
the mutants lost modulation in vitro.
Single-channel Permeability--
Ca2+ release channels
are known to conduct divalent cations such as Ca2+,
Mg2+, and Ba2+ with equal efficiency. Fig.
9 (A-C) shows single-channel
recordings for RyR2, I4829V, and G4828A obtained with 250 mM KCl in the cis chamber and 50 mM
BaCl2 in the trans chamber. At 0 mV, RyR2 and I4829V, a mutant with normal conductance and modulation, showed a
Ba2+ current of 3.5 ± 0.05 pA (n = 3)
and 3.7 ± 0.3 pA (n = 5), respectively (second trace in Fig. 9, A and
B). Under the same conditions, no measurable
Ba2+ current was detected for G4828A (n = 4) (second trace in Fig. 9C). The
current/voltage curves for RyR2, I4829V, and G4828A under these
conditions are presented in Fig. 9 (D-F) and compared with the I/V curves (from Fig. 6A) obtained with 250 mM symmetrical KCl in both chambers. The K+
conductance was 490 ± 23 and 487 ± 45 pS and the
Ba2+ conductance was 186 ± 13 and 187 ± 11 pS
for RyR2 and I4829V, respectively. The K+ and
Ba2+ conductances were similar for G4828A, with a value of
280 ± 27 pS. The reversal potential for these three channels, and
hence the calculated permeability ratio
(p(Ba2+)/p(K+)) (31), are presented in Fig. 9
(inset). They indicate that RyR2 and mutant I4829V have a
limited preference for Ba2+ over K+, but that
mutant G4828A has a similar selectivity for Ba2+ and
K+.

View larger version (36K):
[in this window]
[in a new window]
|
Fig. 9.
Permeability
(Ba2+/K+) of wild type RyR2, I4829V, and
G4828A. Single-channel currents were recorded with the
cis chamber containing a solution of 250 mM KCl,
25 mM Hepes, pH 7.4, and the trans chamber
containing a buffer of 50 mM BaCl2, 25 mM Hepes, pH 7.4. Traces at 40, 0, and +40 mV are shown
for RyR2 (A), I4829V (B), and G4829A
(C). The closed level is indicated by a line
across each trace. Resultant I-V curves are shown
in D for RyR2, in E for I4829V, and in
F for G4828A, compared with I-V curves obtained in
symmetrical 250 mM KCl, as shown in Fig. 6A.
Reversal potentials were obtained from the I-V curves and are indicated
under "Results." Permeability ratios, calculated from the equation:
p(Ba2+)/p(K+) = [K+]cis{[1 + exp( FV/RT)]exp( FV/RT)}/4[BaCl2]trans,
are presented in the inset.
|
|
The conductance for Mg2+ and/or Ca2+ was also
determined for wt and selected RyR2 mutants. Current/voltage curves for
wt, R4824A, and G4828A were obtained under two conditions with 250 mM symmetrical KCl in both chambers: (a) with
contaminating Ca2+ and (b) with 10 mM MgCl2 in the trans chamber. The
I/V curves for K+ current in contaminating Ca2+
was linear for these three channels, showing ohmic voltage dependence (Figs. 6A and 10 (A-C)). The addition of 10 mM MgCl2 (Fig.
10A) or 10 mM
CaCl2 (data not shown) to the trans chamber
reduced the current at both positive and negative holding potentials
and shifted the reversal potential leftward to about 5 mV. Such
phenomena were not seen, however, for mutants R4824A and G4828A after
the addition of 10 mM MgCl2 to the
trans side (Fig. 10, B and C). In wt
RyR2 and the mutants with normal modulation (G4826A, I4829V, and
G4830A), the addition of 3 mM MgCl2 to the
cis chamber resulted in a reduced current of about 30% at
30 mV holding potential (Fig. 10, inset). No change of
current was observed in other mutants under the same conditions (Fig.
10, inset).

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 10.
Permeability
(Mg2+/K+) of wild type RyR2 and mutants.
Single-channel recordings were initially made at symmetrical 250 mM KCl. I-V curves were obtained for RyR2 (A),
R4824A (B), and G4828A (C) before and after 10 mM MgCl2 was added into the trans
chamber. A decrease in single-channel current at 30 mV was obtained
after the addition of 3 mM MgCl2 into the
cis chamber and is presented in Fig. 10
(inset).
|
|
 |
DISCUSSION |
Various mutations in amino acids 4822-4831 of RyR2
Ca2+ release channels alter the sensitivity of channel
opening to caffeine, the ability of the channel to bind
[3H]ryanodine with high affinity, the ability of
ryanodine to activate and inhibit channel function, the unitary
conductance of single channels, the modulation of single channels by
Ca2+ and other endogenous and exogenous agents, and ion
permeability. These results demonstrate the critical role of this
sequence in caffeine activation, ryanodine binding, and ryanodine
activation of Ca2+ release and support the hypothesis that
this region is the pore region of the RyR Ca2+ release
channel, comparable to the P-loop of many voltage-gated ion channels in
the plasma membrane.
This sequence, which connects highly hydrophobic transmembrane
sequences, M8 and M10, was originally predicted to be a transmembrane sequence (M9) (5), but this sequence must now be considered to fold
into the pore structure from the lumenal side (27, 28). Since both the
the NH2 and COOH termini of RyR molecules are located in
the cytoplasm (32), there should be an even number of transmembrane sequences. Of the 10 transmembrane sequences originally proposed (5),
M3 and M4 are not conserved in the family and can be eliminated. Recognition that former M9 probably folds into the pore region eliminates M9 as a transmembrane sequence. Thus, it is likely that at
least one more proposed helix must also be eliminated to reduce the
transmembrane sequences to an even number.
It is complicated to sort out and interpret the possible links among
the large number of functional consequences of mutation of the 12 amino
acids forming part of the pore region. Association was observed between
loss or retention of high affinity [3H]ryanodine binding
and single-channel modulation. Mutants G4826A, I4829V, and G4830A
retained normal Kd for high affinity [3H]ryanodine binding and normal single-channel
modulation. All other mutants lost both [3H]ryanodine
binding and normal single-channel modulation. We did not observe a
correlation between retention of high affinity
[3H]ryanodine binding and ryanodine-induced
Ca2+ release in transfected HEK-293 cells. Mutants I4829V
and G4830A, like wt RyR2, retained high affinity
[3H]ryanodine binding and did not display
ryanodine-induced Ca2+ release, whereas mutant G4826A
retained high affinity [3H]ryanodine binding and gained
the function of ryanodine-induced Ca2+ release in
transfected HEK-293 cells.
Surprisingly, mutants that did not display modulation by agents such as
caffeine, Ca2+, Mg2+, and ATP in single-channel
recordings retained at least low levels of caffeine-induced
Ca2+ release in transfected HEK-293 cells. Thus, there is a
dilemma that channels that are active in whole cells appear inactive
when measured as single-channels. This feature is further complicated by the fact that mutants that did not retain normal modulation in
single-channel recordings did not retain detectable
[3H]ryanodine binding, even in the presence of caffeine,
which favors channel activation. Loss of regulatory factors during the
process of isolation of the protein in the presence of CHAPS is a
possible reason (28), and preliminary results reported here support
this idea.
Single-channel Properties--
Analysis of the single-channel
properties of all mutants in the predicted pore region sequence, except
for G4822A and A4825V, showed that only mutants G4830A and I4829V
retained both normal conductance and normal modulation. With the
further exception of mutants G4830A and I4829V, all had decreased
K+ conductance. Mutant G4826A, with a unitary
K+ conductance of only 27 pS, retained normal modulation by
endogenous and exogenous agents. Similar results have been reported
previously for the same RyR2 mutant (27) and for the corresponding
mutant in RyR1 (28). The unitary K+ conductance of mutants
V4823A, R4824A, G4827A, G4828A, I4829A, I4829T, and D4831A varied
between 340 and 540 pS, compared with 710 pS for the normal channel.
Although this group of mutants retained a higher conductance, they lost
regulatory properties. Mutants G4828A and I4829A or I4829T had
reduced sensitivity to ryanodine and ruthenium red. Many of the mutated
channels, similar to those mutated in the same region in RyR1 (28),
remained open and retained a high Po, even in
the presence of millimolar EGTA, indicating that loss of
Ca2+ regulation was a common feature among these mutants.
It must be stressed, however, that a high probability of channel
opening in these mutant channels under the conditions of single-channel recording might not reflect the in vivo situation. These
channels retained caffeine activation in cellular assays, but were not responsive in single-channel recordings. Unknown cellular factors could
exist that fine-tune channel opening and channel modulation. These
factors could be lost during protein isolation with CHAPS. Single-channel recording with isolated microsomes or direct patch clamping on the nuclear membrane of transfected HEK-293 cells (33)
could be useful in elucidating the mechanisms underlying these events.
RyR Ca2+ release channels have a limited selectivity for
divalent cations as compared with a permeability ratio of more than 1000 for divalent cations over monovalent cations observed for L, N, or
T type Ca2+ channels (31). In L type Ca2+
channels, the molecular determinant of Ca2+ selectivity is
a four-glutamate sequence, the EEEE locus, located in the pore region
of each of the four internal repeats in the Ca2+ channel
1 subunit (34). The results obtained in this study suggest that many amino acids in the pore region of the RyR
Ca2+ release channel, not only those that are negatively
charged, might contribute to the weak selectivity for divalent cations. K+ conductance by the mutants V4823A, R4824A, G4827A,
G4828A, I4829A, I4829T, and D4831A was unimpaired by the presence of
the divalent cations Ca2+, Ba2+, or
Mg2+ in the cis chamber or in the
trans chamber, suggesting that divalent and monovalent
cations were conducted with similar efficiency. Residues adjacent to
this region in RyR1 are also involved in channel selectivity (28).
Single-channel Properties of Mutant I4829T--
Mutation I4897T in
RyR1, equivalent to I4829T in RyR2, is a causal mutation for central
core disease (10). The RyR1 mutation I4897T differed from other CCD and
MH mutations found in MH/CCD domains I and II in the
NH2-terminal portion of RyR1, since it abolished
caffeine-induced Ca2+ release in transfected HEK-293 cells
in the homozygous state, although not in the heterozygous state, and it
lost ryanodine binding. Thus it was proposed that it exists as a highly
leaky channel, which continually depletes Ca2+ stores. The
single-channel properties of the corresponding RyR2 mutant, I4829T,
strongly support this view. The I4829T channel, in the absence of
Ca2+ or any other modulator had an open probability of over
90%. It is, however, possible that channel opening is suppressed
substantially in cells. Thus, even though its conductance was reduced
to about 60% of wt, it would still function as a highly leaky
channel, consistent with the hypothesis that CCD is caused by chronic
elevation of intracellular Ca2+ (7, 35). This hypothesis
has been disputed by Avila et al. (24), who believe that
Ca2+ stores are unaffected by the mutation on the basis of
experiments showing that cyclopiazonic acid-induced Ca2+
transients are similar in dyspedic myoblasts expressing wt or I4897T RyR1.
Both mutants I4829A and I4829T had abnormal single-channel properties.
When I4829 was mutated to Val, the corresponding conserved residue in
IP3 receptors, channel regulation and channel conductance were restored to normal. These results indicate the critical
requirement for a hydrophobic residue in this position. The
corresponding mutation, I4897V, has been reported to decrease channel
conductance in RyR1 (28), whereas V2458I in IP3 receptor
increased channel conductance (33). Our result for I4829V differs from
these two reports. Isoform or species differences may contribute to
phenotypic differences in the expressed proteins.
Caffeine Activation--
Caffeine, an exogenous activator of
Ca2+ release, has been used as a tool for studying
excitation-contraction coupling and the function of Ca2+
release channels (36). It is also used in the clinical diagnosis for
malignant hyperthermia (7). Whereas caffeine sensitivity is useful for
the diagnosis of CCD caused by mutations in MH/CCD domains I and II,
recent evidence that CCD mutations in MH/CCD domain III retain normal
caffeine sensitivity in heterozygous form limits the usefulness of
caffeine sensitivity for the diagnosis of CCD (10).
The binding site for caffeine in RyR has not been defined, largely
because mutations throughout the molecule cause alterations in caffeine
sensitivity. All MH and CCD mutations located in the sequences lying
between amino acids 35 and 614 and between 2162 and 2458 (7) had
increased sensitivity to caffeine and halothane (8, 9), implying
that these domains might be involved in caffeine binding. In support of
this view, expression of the COOH-terminal one-fifth of the RyR1
sequence was sufficient to form a functional Ca2+ release
channel, but the truncated channel was not caffeine-activated (37).
Nevertheless, the COOH-terminal sequence has been linked to caffeine
sensitivity, since deletion of amino acids 4272-4535 increased the
sensitivity of the mutant RyR1 channel to caffeine and Ca2+
(17). The CCD mutation, I4897T in RyR1, found in MH region 3 and
equivalent to I4829T in this study, abolished caffeine-induced Ca2+ release in transfected HEK-293 cells when expressed as
a homozygote, but displayed normal caffeine and halothane sensitivity
when expressed as a heterozygote (10). These observations, together
with the results obtained in this study, indicate that caffeine
activation of RyR channels involves amino acids throughout the sequence
and suggest that caffeine activation is a global and complicated
process. Indeed, caffeine-induced Ca2+ release must include
a number of processes such as ligand binding, consequent conformation
changes, and, finally, channel opening. Mutations in the predicted pore
region could alter structures related to any one of these
processes, altering caffeine sensitivity.
In this study, more evidence is presented for a role of the pore region
in caffeine activation. Mutations I4829A and I4829T abolished
caffeine-induced Ca2+ release in transfected HEK-293 cells;
mutation V4823A increased caffeine sensitivity; mutations G4822A,
R4824A, G4826A, and G4828A decreased caffeine sensitivity; the
remaining mutants retained normal caffeine sensitivity. It is of
interest that loss of caffeine occurred with every other amino acid
starting from G4822, mutants G4828 and I4829 being exceptions.
Ryanodine Binding and Activation--
High affinity
[3H]ryanodine binding occurs in the tetrameric form of
RyR1 in CHAPS, but not in the monomeric form in Zwittergent 3-14 (38).
The binding site has been localized to the COOH-terminal region in the
linear sequence in biochemical studies (18, 19). Studies with ryanoids
have predicted that pyrrole and isopropyl groups are embedded deep
inside a cleft in RyR molecules (39).
Ryanodine activation of Ca2+ release channels exhibits use
dependence. For example, contracture was induced in rat muscles infused with ryanodine and receiving electrical stimuli, but not in
unstimulated muscles (40), indicating that ryanodine did not bind to
RyR in resting muscles. Consistent with this finding, high affinity [3H]ryanodine binding to RyR is observed only when the
channel is activated, indicating that ryanodine binds to an open state
conformation of the channel. Ryanodine is known to increase
Ca2+ permeability of the sarcoplasmic reticulum at
submicromolar concentrations and to decrease Ca2+
permeability at higher concentrations. In single-channel recordings, ryanodine either locks the channel in an open subconductance state with
about 50% of normal conductance or closes the channel (see reviews in
Refs. 1-3).
In this study, 10 µM ryanodine did not stimulate
Ca2+ release in HEK-293 cells expressing wt RyR2 channels.
By contrast, 10 µM ryanodine did stimulate
Ca2+ release in HEK-293 cells expressing mutants in amino
acids 4823-4827. Ca2+ release occurred under resting
conditions that would not favor channel opening, normally considered to
be a prerequisite to ryanodine binding. This was especially surprising,
since most mutations in the pore region caused loss of high affinity
[3H]ryanodine binding to CHAPS-solubilized proteins.
These results imply that the high affinity binding site in RyR2 is
retained in mutants of amino acids 4823-4837, but with possible
alterations in affinity or dissociation rate that were not measurable
in our binding assay. One exception is mutant G4826A, which possessed a
normal Kd for [3H]ryanodine binding
but gained the ryanodine activation function.
In order to exclude a possible effect of CHAPS, we tested
[3H]ryanodine binding to isolated microsomes and to whole
cells with plasma membranes either intact or permeabilized with
saponin, in the presence and absence of 10 mM caffeine. No
[3H]ryanodine binding to whole cells or to microsomes was
observed for any of the mutants previously found to lack
[3H]ryanodine binding, but binding was consistently
positive for wild type (data not shown).
These observations raise the possibility that the pore region is
involved in high affinity ryanodine binding in RyR. However, this
region is also highly conserved among IP3 receptors, which do not bind ryanodine. Thus, these amino acids are probably essential, but not the sole components of the high affinity ryanodine binding site. The location of these residues is consistent with the finding that the high affinity ryanodine and perhaps the low affinity binding
sites are located in the COOH-terminal 76 kDa of the RyR molecule (18,
19).
Ryanodine Restoration of Caffeine-induced Ca2+
Release--
The addition of 10 µM ryanodine to wt RyR2
did not inhibit caffeine-induced Ca2+ release in
transfected HEK-293 cells. However, the addition of ryanodine did
inhibit the amplitude of Ca2+ release induced by subsequent
additions of caffeine, eventually leading to abolition of
Ca2+-induced Ca2+ release. This pattern is
believed to result from the fact that ryanodine binds to the open state
of the channel, induced by caffeine, and blocks the channel in an open
subconductance state, preventing the accumulation of a Ca2+
store. This behavior pattern was shared with mutants I4829V and G4830A.
Mutants I4829A and G4829T, however, exhibited a different pattern.
Neither 10 mM caffeine nor 10 µM ryanodine
induced Ca2+ release when these mutants were transfected
into HEK-293 cells. However, if these cells were incubated in the
presence of 10 µM ryanodine, the subsequent addition of
10 mM caffeine restored and enhanced caffeine-induced
Ca2+ release. When the two compounds were added
simultaneously, a much slower rate of Ca2+ release was
observed (data not shown). These results indicate that these mutant
channels retain the ability to bind ryanodine (perhaps with lower
affinity) and that binding of ryanodine to the molecule stabilizes a
channel conformation that favors caffeine activation.
Mutation E4032A in RyR1 was found to be caffeine- and
4-chloro-m-cresol-insensitive when expressed in HEK-293
cells (20). The corresponding mutation in RyR3, E3885, was found to be
more than 1000-fold less sensitive to Ca2+ activation than
wt when subjected to single-channel analysis and was proposed to form
part of the Ca2+ sensor site (14). Recently, prior addition
of 200-500 µM ryanodine to cells expressing the E4032A
mutant has been shown to restore caffeine and
4-chloro-m-cresol sensitivity to the mutant channel (41).
These observations are similar to our observations with mutants G4828A
and I4829A or I4829T. It was proposed that ryanodine binds to
the E4032A mutant with low affinity and induces allosteric changes in
the structure of the protein that restore caffeine activation (41). It
is of interest that residues Gly4828 and
Ile4829 are located in the pore region, whereas
Glu4032 is located in predicted transmembrane sequence 2. If these residues interact to form a ryanodine binding site, TM2 might
lie close to the pore sequence.
Hypothesis for Ryanodine Restoration of Caffeine Activation in
I4829T (CCD) Mutant--
If we consider wt and mutants I4829V and
G4830A to form one functional class (class 1) and mutants G4828A,
I4829A, and G4829T to form a second functional class (class 2) of RyR2
channels, we can compare several of their respective properties. Class
1 molecules have the following properties described in this paper: 1)
low probability of opening in the presence of trace Ca2+;
2) high conductance; 3) caffeine-induction of Ca2+ release
in HEK-293 cells; 4) activation of channel opening by caffeine,
Ca2+, and ATP and inhibition by Mg2+ and
inhibition of the channel by EGTA; 5) high affinity
[3H]ryanodine binding; 6) modulation of channel opening
by low concentrations of ryanodine; 7) lack of ryanodine activation of
caffeine-induced Ca2+ release. By contrast, class 2 mutants
have the following, largely opposite characteristics: 1) high
probability of opening in the presence of trace Ca2+; 2)
~25% reduced conductance; 3) lack of caffeine induction of Ca2+ release in HEK-293 cells; 4) lack of activation of
channel opening by caffeine, Ca2+, and ATP and lack of
inhibition by Mg2+ or by EGTA; 5) lack of high affinity
[3H]ryanodine binding; 6) lack of modulation of channel
opening by low concentrations of ryanodine; 7) ryanodine activation of caffeine-induced Ca2+ release.
The different behavior of class 1 and class 2 mutants might be
explained by a series of simple hypotheses. In single-channel analysis,
which does not mimic the ionic or protein composition of whole cells
and organelles, class 2 mutants have a high, largely unregulated
probability of opening. If these channels were also open in HEK-293
cells, then they would not respond to caffeine activation, not
necessarily because the caffeine activation site had been altered, but
simply because they would have emptied Ca2+ stores,
creating a futile cycle of Ca2+ uptake and release. Class 2 mutations have very low affinity for ryanodine, and we propose that
class 2 mutations affect the structure of the pore in a way that leads
to a low affinity interaction with ryanodine. Low affinity interactions
with ryanodine may be able to block Ca2+ conductance, but
not hold the channel in a subconductance state. We propose that, in the
cellular environment, the low affinity binding of ryanodine to open
mutant channels leads to their full or partial blockage. Blockage of
these channels by ryanodine would then allow a Ca2+ store
to build up, which can be released by subsequent additions of caffeine.
Ryanodine might be completely displaced from its altered, lower
affinity binding site by allosteric effects of caffeine activation.
Alternatively, low affinity ryanodine binding might induce closure,
rather than blockage of the mutant channel, and it might, through
allosteric mechanisms, induce a caffeine-sensitive state. It is
unfortunate that we cannot directly equate results obtained in whole
cells with results obtained in single-channel analysis, probably
because cellular conditions cannot be recreated in isolation. Thus, we
cannot reproduce ryanodine restoration of caffeine activation in single
channels even though the phenomenon can be observed in whole cells.
These hypotheses will be pursued in future studies.
Although these hypotheses might explain class 1 and class 2 channel
behavior, at least two other classes of mutants can be identified that
do not fall into these categories. Mutant G4826A is similar to class 1 mutants, but has a very low conductance and displays ryanodine-induced
Ca2+ release. Mutants V4823A and R4824A have very high
probability of unregulated opening, like class 2 mutants, but have
ryanodine-induced Ca2+ release and do not have ryanodine
restoration of caffeine activation. Thus different behaviors arise from
mutations in the pore region. A better understanding of the structure
of the pore and mutant-induced modification of this structure would be
very useful in understanding how mutations modify structure and function.
In summary, our data demonstrate that different mutations in the highly
conserved sequence, GVRAGGGIGD4831, in the RyR2
Ca2+ release channel can alter single-channel conductance,
ion selectivity, caffeine sensitivity, high affinity
[3H]ryanodine binding, and the ability of ryanodine to
modulate Ca2+ release. These results support the proposal
that this region contributes to the formation of the channel pore. The
fact that other mutations in the predicted transmembrane sequences in
our previous study (20) and mutations in the predicted pore region in
the present study abolished caffeine activation and
[3H]ryanodine binding suggests that all of these amino
acids are critical to channel function and its regulation.
 |
ACKNOWLEDGEMENT |
We thank Stella de Leon for expert technical assistance.
 |
FOOTNOTES |
*
This work was supported in part by Grant MT-3399 (to D. H. M.) from the Canadian Institutes for Health Research.
Postdoctoral fellow of the Heart and Stroke Foundation of Canada.
§
To whom correspondence should be addressed: Banting and Best Dept.
of Medical Research, University of Toronto, Charles H. Best Inst., 112 College St., Toronto, Ontario M5G 1L6, Canada. Tel.:
416-978-5008; Fax: 416-978-8528; E-mail:
david.maclennan@utoronto.ca.
Published, JBC Papers in Press, June 26, 2001, DOI 10.1074/jbc.M102751200
 |
ABBREVIATIONS |
The abbreviations used are:
RyR, ryanodine
receptor;
RyR2, the cardiac muscle ryanodine receptor isoform;
CHAPS, 3-[(3-cholamidopropyl)dimethylammonio-]-1-propanesulfonic acid;
HEK-293, human embryonic kidney cell line 293;
CCD, central core
disease;
MH, malignant hyperthermia;
wt, wild type;
IP3, inositol 1,4,5-trisphosphate;
PC, phosphatidylcholine;
TM, transmembrane;
pS, picosiemen(s);
AM, acetoxymethyl ester;
AEBSF, 4(2-aminoethyl) benzenesulfonylfluoride.
 |
REFERENCES |
| 1.
|
Meissner, G.
(1994)
Annu. Rev. Physiol.
56,
485-508
|
| 2.
|
Franzini-Armstrong, C.,
and Protasi, F.
(1997)
Physiol. Rev.
77,
699-729
|
| 3.
|
Zucchi, R.,
and Ronca-Testoni, S.
(1997)
Pharmacol. Rev.
49,
53-98
|
| 4.
|
Takeshima, H.,
Nishimura, S.,
Matsumoto, T.,
Ishida, H.,
Kangawa, K.,
Minamino, N.,
Matsuo, H.,
Ueda, M.,
Hanaoka, M.,
Hirose, T.,
and Numa, S.
(1989)
Nature
339,
439-445
|
| 5.
|
Zorzato, F.,
Fujii, J.,
Otsu, K.,
Phillips, M.,
Green, N. M.,
Lai, F. A.,
Meissner, G.,
and MacLennan, D. H.
(1990)
J. Biol. Chem.
265,
2244-2256
|
| 6.
|
Otsu, K.,
Willard, H. F.,
Khanna, V. K.,
Zorzato, F.,
Green, N. M.,
and MacLennan, D. H.
(1990)
J. Biol. Chem.
265,
13472-13483
|
| 7.
|
Loke, J.,
and MacLennan, D. H.
(1998)
Am. J. Med.
104,
470-486
|
| 8.
|
Tong, J.,
Oyamada, H.,
Demaurex, N.,
Grinstein, S.,
McCarthy, T. V.,
and MacLennan, D. H.
(1997)
J. Biol. Chem.
272,
26332-26339
|
| 9.
|
Tong, J.,
McCarthy, T. V.,
and MacLennan, D. H.
(1999)
J. Biol. Chem.
274,
693-702
|
| 10.
|
Lynch, P. J.,
Tong, J.,
Lehane, M.,
Mallet, A.,
Giblin, L.,
Heffron, J. J.,
Vaughan, P.,
Zafra, G.,
MacLennan, D. H.,
and McCarthy, T. V.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
4164-4169
|
| 11.
|
Priori, S. G.,
Napolitano, C.,
Tiso, N.,
Memmi, M.,
Vignati, G.,
Bloise, R.,
Sorrentino, V.,
and Danieli, G. A.
(2001)
Circulation
103,
196-200
|
| 12.
|
Tiso, N.,
Stephan, D. A.,
Nava, A.,
Bagattin, A.,
Devaney, J. M.,
Stanchi, F.,
Larderet, G.,
Brahmbhatt, B.,
Brown, K.,
Bauce, B.,
Muriago, M.,
Basso, C.,
Thiene, G.,
Danieli, G. A.,
and Rampazzo, A.
(2001)
Hum. Mol. Genet.
10,
189-194
|
| 13.
|
Bhat, M. B.,
Zhao, J.,
Takeshima, H.,
and Ma, J.
(1997)
Biophys. J.
73,
1329-1336
|
| 14.
|
Chen, S. R. W.,
Ebisawa, K.,
Li, X.,
and Zhang, L.
(1998)
J. Biol. Chem.
273,
14675-14678
|
| 15.
|
Du, G. G.,
and MacLennan, D. H.
(1999)
J. Biol. Chem.
274,
26120-26126
|
| 16.
|
Nakai, J.,
Gao, L.,
Xu, L.,
Xin, C.,
Pasek, D. A.,
and Meissner, G.
(1999)
FEBS Lett.
459,
154-158
|
| 17.
|
Du, G. G.,
Khanna, V. K.,
and MacLennan, D. H.
(2000)
J. Biol. Chem.
275,
11778-83
|
| 18.
|
Callaway, C.,
Seryshev, A.,
Wang, J. P.,
Slavik, K. J.,
Needleman, D. H.,
Cantu, C., III,
Wu, Y.,
Jayaraman, T.,
Marks, A. R.,
and Hamilton, S. L.
(1994)
J. Biol. Chem.
269,
15876-15884
|
| 19.
|
Witcher, D. R.,
McPherson, P. S.,
Kahl, S. D.,
Lewis, T.,
Bentley, P.,
Mullinnix, M. J.,
Windass, J. D.,
and Campbell, K. P.
(1994)
J. Biol. Chem.
269,
13076-13079
|
| 20.
|
Du, G. G.,
and MacLennan, D. H.
(1998)
J. Biol. Chem.
273,
31867-31872
|
| 21.
|
Chen, S. R.,
and MacLennan, D. H.
(1994)
J. Biol. Chem.
269,
22698-22704
|
| 22.
|
Menegazzi, P.,
Larini, F.,
Treves, S.,
Guerrini, R.,
Quadroni, M.,
and Zorzato, F.
(1994)
Biochemistry
33,
9078-9084
|
| 23.
|
Moore, C. P.,
Zhang, J. Z.,
and Hamilton, S. L.
(1999)
J. Biol. Chem.
274,
36831-36834
|
| 24.
|
Avila, G.,
O'Brien, J. J.,
and Dirksen, R. T.
(2001)
Proc. Natl. Acad. Sci. U. S. A.
98,
4215-4220
|
| 25.
|
Doyle, D. A.,
Morais Cabral, J.,
Pfuetzner, R. A.,
Kuo, A.,
Gulbis, J. M.,
Cohen, S. L.,
Chait, B. T.,
and MacKinnon, R.
(1998)
Science
280,
69-77
|
| 26.
|
Balshaw, D.,
Gao, L.,
and Meissner, G.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
3345-3347
|
| 27.
|
Zhao, M.,
Li, P.,
Li, X.,
Zhang, L.,
Winkfein, R. J.,
and Chen, S. R.
(1999)
J. Biol. Chem.
274,
25971-25974
|
| 28.
|
Gao, L.,
Balshaw, D.,
Xu, L.,
Tripathy, A.,
Xin, C.,
and Meissner, G.
(2000)
Biophys. J.
79,
828-840
|
| 29.
|
Chen, S. R.,
Leong, P.,
Imredy, J. P.,
Bartlett, C.,
Zhang, L.,
and MacLennan, D. H.
(1997)
Biophys. J.
73,
1904-1912
|
| 30.
|
Du, G. G.,
Imredy, J. P.,
and MacLennan, D. H.
(1998)
J. Biol. Chem.
273,
33259-33266
|
| 31.
|
Lee, K. S.,
and Tsien, R. W.
(1984)
J. Physiol. (Lond.)
354,
253-272
|
| 32.
|
Grunwald, R.,
and Meissner, G.
(1995)
J. Biol. Chem.
270,
11338-11347
|
| 33.
|
Boehning, D.,
Mak, D. O.,
Foskett, J. K.,
and Joseph, S. K.
(2001)
J. Biol. Chem.
276,
13509-13512
|
| 34.
|
Yang, J.,
Ellinor, P. T.,
Sather, W. A.,
Zhang, J. F.,
and Tsien, R. W.
(1993)
Nature
366,
158-161
|
| 35.
|
MacLennan, D. H.,
and Phillips, M. S.
(1995)
Soc. Gen. Physiol. Ser.
50,
89-100
|
| 36.
|
Herrmann-Frank, A.,
Luttgau, H. C.,
and Stephenson, D. G.
(1999)
J. Muscle Res. Cell Motil.
20,
223-237
|
| 37.
|
Bhat, M. B.,
Zhao, J.,
Zang, W.,
Balke, C. W.,
Takeshima, H.,
Wier, W. G.,
and Ma, J.
(1997)
J. Gen. Physiol.
110,
749-762
|
| 38.
|
Lai, F. A.,
Misra, M.,
Xu, L.,
Smith, H. A.,
and Meissner, G.
(1989)
J. Biol. Chem.
264,
16776-16785
|
| 39.
|
Welch, W.,
Sutko, J. L.,
Mitchell, K. E.,
Airey, J.,
and Ruest, L.
(1996)
Biochemistry
35,
7165-7173
|
| 40.
|
Procita, L.
(1956)
J. Pharmacol. Exp. Ther.
117,
363-373
|
| 41.
|
Fessenden, J. D.,
Chen, L.,
Wang, Y.,
Paolini, C.,
Franzini-Armstrong, C.,
Allen, P. D.,
and Pessah, I. N.
(2001)
Proc. Natl. Acad. Sci. U. S. A.
98,
2865-2870
|
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
Z. T. Schug, P. C. A. da Fonseca, C. D. Bhanumathy, L. Wagner II, X. Zhang, B. Bailey, E. P. Morris, D. I. Yule, and S. K. Joseph
Molecular Characterization of the Inositol 1,4,5-Trisphosphate Receptor Pore-forming Segment
J. Biol. Chem.,
February 1, 2008;
283(5):
2939 - 2948.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Meur, A. K. T. Parker, F. V. Gergely, and C. W. Taylor
Targeting and Retention of Type 1 Ryanodine Receptors to the Endoplasmic Reticulum
J. Biol. Chem.,
August 10, 2007;
282(32):
23096 - 23103.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. K. Foskett, C. White, K.-H. Cheung, and D.-O. D. Mak
Inositol Trisphosphate Receptor Ca2+ Release Channels
Physiol Rev,
April 1, 2007;
87(2):
593 - 658.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. M. Ranatunga, T. M. Moreno-King, B. Tanna, R. Wang, S. R. W. Chen, L. Ruest, W. Welch, and A. J. Williams
The Gln4863Ala Mutation within a Putative, Pore-Lining Trans-Membrane Helix of the Cardiac Ryanodine Receptor Channel Alters Both the Kinetics of Ryanoid Interaction and the Subsequent Fractional Conductance
Mol. Pharmacol.,
September 1, 2005;
68(3):
840 - 846.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Brini, S. Manni, N. Pierobon, G. G. Du, P. Sharma, D. H. MacLennan, and E. Carafoli
Ca2+ Signaling in HEK-293 and Skeletal Muscle Cells Expressing Recombinant Ryanodine Receptors Harboring Malignant Hyperthermia and Central Core Disease Mutations
J. Biol. Chem.,
April 15, 2005;
280(15):
15380 - 15389.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. Zhang, M. Kohler, S.-N. Yang, F. Zhang, O. Larsson, and P.-O. Berggren
Growth Hormone Promotes Ca2+-Induced Ca2+ Release in Insulin-Secreting Cells by Ryanodine Receptor Tyrosine Phosphorylation
Mol. Endocrinol.,
July 1, 2004;
18(7):
1658 - 1669.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. H. George, H. Jundi, N. L. Thomas, M. Scoote, N. Walters, A. J. Williams, and F. A. Lai
Ryanodine Receptor Regulation by Intramolecular Interaction between Cytoplasmic and Transmembrane Domains
Mol. Biol. Cell,
June 1, 2004;
15(6):
2627 - 2638.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. M. Gallant, J. Hart, K. Eager, S. Curtis, and A. F. Dulhunty
Caffeine sensitivity of native RyR channels from normal and malignant hyperthermic pigs: effects of a DHPR II-III loop peptide
Am J Physiol Cell Physiol,
April 1, 2004;
286(4):
C821 - C830.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Wang, J. Bolstad, H. Kong, L. Zhang, C. Brown, and S. R. W. Chen
The Predicted TM10 Transmembrane Sequence of the Cardiac Ca2+ Release Channel (Ryanodine Receptor) Is Crucial for Channel Activation and Gating
J. Biol. Chem.,
January 30, 2004;
279(5):
3635 - 3642.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Wang, L. Zhang, J. Bolstad, N. Diao, C. Brown, L. Ruest, W. Welch, A. J. Williams, and S. R. W. Chen
Residue Gln4863 within a Predicted Transmembrane Sequence of the Ca2+ Release Channel (Ryanodine Receptor) Is Critical for Ryanodine Interaction
J. Biol. Chem.,
December 19, 2003;
278(51):
51557 - 51565.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Zorzato, N. Yamaguchi, L. Xu, G. Meissner, C. R. Muller, P. Pouliquin, F. Muntoni, C. Sewry, T. Girard, and S. Treves
Clinical and functional effects of a deletion in a COOH-terminal lumenal loop of the skeletal muscle ryanodine receptor
Hum. Mol. Genet.,
February 15, 2003;
12(4):
379 - 388.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. G. Du, B. Sandhu, V. K. Khanna, X. H. Guo, and D. H. MacLennan
Topology of the Ca2+ release channel of skeletal muscle sarcoplasmic reticulum (RyR1)
PNAS,
December 24, 2002;
99(26):
16725 - 16730.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. G. Du, X. Guo, V. K. Khanna, and D. H. MacLennan
Ryanodine sensitizes the cardiac Ca2+ release channel (ryanodine receptor isoform 2) to Ca2+ activation and dissociates as the channel is closed by Ca2+ depletion
PNAS,
October 31, 2001;
(2001)
241516898.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. G. Du, X. Guo, V. K. Khanna, and D. H. MacLennan
Ryanodine sensitizes the cardiac Ca2+ release channel (ryanodine receptor isoform 2) to Ca2+ activation and dissociates as the channel is closed by Ca2+ depletion
PNAS,
November 20, 2001;
98(24):
13625 - 13630.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|